The Scientist - Home

Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, showing major survival gains in clinical trials. 

Serendipitous observations have shaped science for centuries. What happens to such discoveries when the academic atmosphere leaves no room for detours?

Scientists surveyed said that electronic lab notebooks often fail in fundamental research tasks, including recording and recalling experimental data.

Researchers have shown that harmful bonds between protein and DNA fuel immune attack in progeria. Pumping up a protein that cuts these bonds could prevent symptoms.

An external lung system sustained a patient with severe respiratory failure. Molecular analysis confirmed irreversible lung damage and the procedure’s necessity.

Gut microbes engineered to dim their fluorescence under stress offered a real-time, noninvasive biosensor to track gut health in mice.

Nicole Steinmetz engineers plant virus nanoparticles into versatile drug-delivery platforms. This work expanded into cancer vaccines and immunotherapy.

This postdoc investigates cancer progression and tests innovative anti-tumor strategies in pre-clinical models.

A new analysis method to measure PFAS chemicals suggests while older PFAS are declining, newer PFAS chemicals may be accumulating in the environment in unexpected ways.

A new cohort study found that specific gut bacteria contribute to auto-brewery syndrome, spurring studies into how fecal microbiota transplants may reverse it.